Johnson & Johnson Secures Option to Acquire Sail Biomedicines, Marking Major Bet on In Vivo CAR-T for Autoimmune Diseases
admin Pharmaceutical giant Johnson & Johnson has taken a significant step into the burgeoning field of...
Biotech, Pharma & Cancer Drug Development
Alnylam Pharmaceuticals Faces Sharp Market Reversal as Amvuttra Sales Miss and Guidance Cut Trigger 30% Stock Plunge
Cambridge, MA – Alnylam Pharmaceuticals, a pioneering force in RNA interference (RNAi) therapeutics, experienced a...
FDA Advisory Panel Recommends Replimune’s RP1 for Advanced Melanoma, Overriding Agency Scientist Concerns and Paving Way for Crucial Approval
In a pivotal decision that could redefine treatment pathways for a challenging subset of melanoma...
Hims & Hers Faces Federal Scrutiny Over Allegations of Health Data Sharing and Deceptive Subscription Practices
A federal lawsuit filed in California has cast a significant shadow over Hims & Hers,...
Vertex Pharmaceuticals Partners with AbCellera to Advance T-Cell Engagers for Autoimmune Diseases, Bolstering Diversification Efforts
Vertex Pharmaceuticals, a biopharmaceutical giant predominantly known for its transformative cystic fibrosis treatments, has officially...
MapLight Therapeutics’ Schizophrenia Drug Navigates Investor Skepticism Amidst Promising Clinical Data and Broader Therapeutic Potential
Despite announcing positive results from a pivotal Phase 2b study for its experimental schizophrenia medicine...
FDA Advisory Committee Delivers Blow to Capricor’s Duchenne Therapy Amidst Contentious Regulatory Review and Statistical Discrepancies
In a closely watched decision that underscores the complex and often contentious landscape of rare...
Caldera, Vidya add to recent flurry of biotech mergers
The dynamic landscape of biotechnology witnessed a significant strategic shift this week as two burgeoning...
From Protocol to Patient: Inside Clinical Supply
The intricate journey of bringing scientific breakthroughs from the laboratory to patients worldwide is fraught...
Sarepta Therapeutics Appoints Michael Severino as New CEO Amidst Critical Strategic Crossroads and Post-Elevidys Challenges
Sarepta Therapeutics, a biopharmaceutical company at the forefront of genetic medicine for rare diseases, has...
